🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of i.v. infusi...
Status
Terminated
Location
National Cheng Kung University Hospital
Start Date
2017-04-30
Trial ID
NCT03020823
Treatments Being Tested
The purpose of this study is to assess immune response and safety of variou...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-03
Trial ID
NCT05084508
Treatments Being Tested
A randomized, single-blinded clinical pilot study to assess whether vaccina...
Status
Completed
Location
Department of Internal Medicine, Section of Respiratory Medicine
Start Date
2024-02-28
Trial ID
NCT06257212
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
Phase II trial to determine the efficacy of Dose Adjusted-EPOCH-Rituximab r...
Status
Completed
Location
University Hospitals Leuven
Start Date
2012-04-01
Trial ID
NCT01516567
Treatments Being Tested
Phase II, multicenter, randomized trial, exploring intensified Rituximab pr...
Status
Completed
Location
Stephane LEPRETRE
Start Date
2011-05
Trial ID
NCT01370772
Treatments Being Tested
To evaluate the efficacy of celecoxib combined with R-CHOP versus R-CHOP in...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-03-06
Trial ID
NCT07494565
Treatments Being Tested